Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Erlotinib | 0.031623 | uM | 8 | 1250.00 | 894.42 | 2525.00 | 2189.25 | 1.1534 | 1.2336 |
| SK-BR-3 | Lapatinib | 0.31623 | uM | 8 | 1250.00 | 894.42 | 1114.00 | 2189.25 | 0.5089 | 0.1853 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 8 | 1250.00 | 894.42 | 2410.00 | 2189.25 | 1.1008 | 1.1545 |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 2310.00 | 2189.25 | 1.0552 | 1.0849 | |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 8 | 1250.00 | 894.42 | 2130.00 | 2189.25 | 0.9729 | 0.9580 |
| SK-BR-3 | Erlotinib | 10 | uM | 8 | 1250.00 | 894.42 | 1273.00 | 2189.25 | 0.5815 | 0.3143 |
| SK-BR-3 | 17-AAG | 0.001 | uM | 8 | 1250.00 | 894.42 | 2169.00 | 2189.25 | 0.9908 | 0.9857 |
| SK-BR-3 | Lapatinib | 10 | uM | 8 | 1250.00 | 894.42 | 1073.00 | 2189.25 | 0.4901 | 0.1514 |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 2441.00 | 2189.25 | 1.1150 | 1.1759 | |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 2333.00 | 2189.25 | 1.0657 | 1.1010 | |
| SK-BR-3 | 17-AAG | 0.000066069 | uM | 8 | 1250.00 | 894.42 | 2052.00 | 2189.25 | 0.9373 | 0.9022 |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 2092.00 | 2189.25 | 0.9556 | 0.9309 | |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 1834.00 | 2189.25 | 0.8377 | 0.7438 | |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 1768.00 | 2189.25 | 0.8076 | 0.6950 | |
| SK-BR-3 | 0 | uM | 8 | 1250.00 | 894.42 | 1872.00 | 2189.25 | 0.8551 | 0.7717 | |
| SK-BR-3 | Erlotinib | 0.01 | uM | 8 | 1250.00 | 894.42 | 1922.00 | 2189.25 | 0.8779 | 0.8082 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 8 | 1250.00 | 894.42 | 1590.00 | 2189.25 | 0.7263 | 0.5613 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 8 | 1250.00 | 894.42 | 831.00 | 2189.25 | 0.3796 | -0.0554 |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 8 | 1250.00 | 894.42 | 1282.00 | 2189.25 | 0.5856 | 0.3215 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 8 | 1250.00 | 894.42 | 2018.00 | 2189.25 | 0.9218 | 0.8778 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 8 | 1250.00 | 894.42 | 2334.00 | 2189.25 | 1.0661 | 1.1017 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 8 | 1250.00 | 894.42 | 1650.00 | 2189.25 | 0.7537 | 0.6067 |
| SK-BR-3 | 17-AAG | 0.031623 | uM | 8 | 1250.00 | 894.42 | 1028.00 | 2189.25 | 0.4696 | 0.1138 |
| SK-BR-3 | Lapatinib | 0.1 | uM | 8 | 1250.00 | 894.42 | 1231.00 | 2189.25 | 0.5623 | 0.2806 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 1250.00 | 894.42 | 2415.00 | 2189.25 | 1.1031 | 1.1579 |